Katherine Lu
Impact in
Papers in
-
- Cancer therapeutics and mechanisms 9
- Biochemical and Molecular Research 3
- Oncology 11
- Cancer Treatment and Pharmacology 5
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Ti Li Loo (23 shared papers)Niramol Savaraj (18 shared papers)Robert S. Benjamin (9 shared papers)Lynn G. Feun (10 shared papers)Hwee‐Yong Yap (2 shared papers)T. L. Loo (6 shared papers)Stephen W. Hall (4 shared papers)John A. Benvenuto (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (12 papers)Journal of Neuro-Oncology (6 papers)Cancer Investigation (3 papers)Biochimie (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Katherine Lu
34 papers receiving 515 citations
Peers
Comparison fields: 5 of 70
- Genetics 107
- Oncology 273
- Toxicology 14
- Pharmacology 35
- Hematology 42
Countries citing papers authored by Katherine Lu
This map shows the geographic impact of Katherine Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Lu more than expected).
Fields of papers citing papers by Katherine Lu
This network shows the impact of papers produced by Katherine Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Lu. The network helps show where Katherine Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans. | 1978 | 56 |
| 2 | 1982 | 54 | |
| 3 | Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule. | 1984 | 49 |
| 4 | 1983 | 47 | |
| 5 | Clinical pharmacokinetics of vinblastine by continuous intravenous infusion. | 1983 | 39 |
| 6 | 1983 | 35 | |
| 7 | 1986 | 33 | |
| 8 | 1984 | 27 | |
| 9 | 1982 | 24 | |
| 10 | 1987 | 19 | |
| 11 | 1988 | 15 | |
| 12 | Pharmacological disposition of 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate in the dog. | 1980 | 14 |
| 13 | 1982 | 13 | |
| 14 | 1978 | 12 | |
| 15 | 1978 | 11 | |
| 16 | 1987 | 11 | |
| 17 | 2013 | 11 | |
| 18 | 1979 | 11 | |
| 19 | 1992 | 10 | |
| 20 | 1984 | 8 |
About Katherine Lu
Katherine Lu is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 38 papers that have together received 555 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Cancer Treatment and Pharmacology (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Lanthanide and Transition Metal Complexes (4 papers), Biochemical and Molecular Research (3 papers), Glioma Diagnosis and Treatment (3 papers), Metabolism and Genetic Disorders (3 papers) and Chemical synthesis and alkaloids (3 papers). The work is most often cited by research in Genetics (107 citations), Oncology (273 citations), Toxicology (14 citations), Pharmacology (35 citations) and Hematology (42 citations). Katherine Lu has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Ti Li Loo, Niramol Savaraj, Robert S. Benjamin, Lynn G. Feun, Hwee‐Yong Yap, T. L. Loo, Stephen W. Hall, John A. Benvenuto, Gerald P. Bodey and Michael A. Burgess. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Neuro-Oncology, Cancer Investigation, Biochimie and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.